The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-cyano-4-(cyclohexylmethoxy))phenylpyrimidine-5-carboxylic acid ID: ALA5203944
PubChem CID: 168293752
Max Phase: Preclinical
Molecular Formula: C19H19N3O3
Molecular Weight: 337.38
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1cc(-c2ncc(C(=O)O)cn2)ccc1OCC1CCCCC1
Standard InChI: InChI=1S/C19H19N3O3/c20-9-15-8-14(18-21-10-16(11-22-18)19(23)24)6-7-17(15)25-12-13-4-2-1-3-5-13/h6-8,10-11,13H,1-5,12H2,(H,23,24)
Standard InChI Key: LTOBJEZKUDLRAI-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
-1.0698 0.6213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3553 1.0336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3566 0.6217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3566 -0.2034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3534 -0.6152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0698 -0.2071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0712 1.0343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0714 1.8595 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7843 2.2702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4992 1.8575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5007 1.0364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7889 0.6199 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3534 -1.4404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3534 -2.2656 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2137 2.2701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2137 3.0953 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9284 1.8575 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7844 -0.6197 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7844 -1.4449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4991 -1.8575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4991 -2.6827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2137 -1.4449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2137 -3.0953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9284 -1.8575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9284 -2.6827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
7 3 1 0
8 7 2 0
9 8 1 0
10 9 2 0
11 10 1 0
7 12 1 0
12 11 2 0
5 13 1 0
13 14 3 0
10 15 1 0
15 16 2 0
15 17 1 0
6 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
20 22 1 0
21 23 1 0
22 24 1 0
23 25 1 0
24 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 337.38Molecular Weight (Monoisotopic): 337.1426AlogP: 3.67#Rotatable Bonds: 5Polar Surface Area: 96.10Molecular Species: ACIDHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.84CX Basic pKa: 1.02CX LogP: 3.64CX LogD: 0.37Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.89Np Likeness Score: -1.10
References 1. Zhao J, Mao Q, Lin F, Zhang B, Sun M, Zhang T, Wang S.. (2022) Intramolecular hydrogen bond interruption and scaffold hopping of TMC-5 led to 2-(4-alkoxy-3-cyanophenyl)pyrimidine-4/5-carboxylic acids and 6-(4-alkoxy-3-cyanophenyl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-ones as potent pyrimidine-based xanthine oxidase inhibitors., 229 [PMID:34992040 ] [10.1016/j.ejmech.2021.114086 ]